COVID-19: a viewpoint from hepatic perspective

Abstract: Coronaviruses as such are known since last century. The name is derived from their shape which has crown (corona) like radiating spikes. The recent one however is a different one from the Coronavirus involved in SARS (2002–2004) and MERS (2012) in being highly infectious. Initially COVID 19 had a high case fatality rate which has now decreased to a significant extent. Many cases of COVID 19 are asymptomatic with a significant number of positive cases developing a triad of fever, breathlessness and GI symptoms. Recent travel increases the probability of infection. The pathogenesis involves ACE 2 receptors. So, it has been found that there are more cases and mortality among hypertensive individuals. Even higher among the people who use ACE inhibitor in comparison to those who use other anti-hypertensive drugs. Treatment is usually symptomatic. Antiviral drugs and vaccines against COVID-19 are being used. Deranged liver enzymes are common in COVID-19, however, serious liver injury is not much documented. Liver injury is either due to disease itself or due to antiviral drugs. Extra care like strict social distancing, avoiding unnecessary contact is needed for those with autoimmune hepatitis, liver cancer and those who are in immunosuppression because of a scheduled or already liver transplant. Further research is definitely needed in this field. The upcoming researches should also focus on liver injuries associated with disease course and derangements arising as side effects of treatment of COVID-19.

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
COVID-19: a viewpoint from hepatic perspective ; volume:44 ; number:1 ; year:2022 ; pages:97-103 ; extent:07
Hormone molecular biology and clinical investigation ; 44, Heft 1 (2022), 97-103 (gesamt 07)

Urheber
Brizawasi, Abhijeet
Ahirwar, Ashok Kumar
Prabhat
Kaim, Kirti
Ahirwar, Pradeep
Kumawat, Rajani
Prasad, Jitender

DOI
10.1515/hmbci-2022-0026
URN
urn:nbn:de:101:1-2023033014092043616242
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:59 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Beteiligte

  • Brizawasi, Abhijeet
  • Ahirwar, Ashok Kumar
  • Prabhat
  • Kaim, Kirti
  • Ahirwar, Pradeep
  • Kumawat, Rajani
  • Prasad, Jitender

Ähnliche Objekte (12)